For decades, pharmacies have relied on a simple industry tradition: Loan & Borrow.
One pharmacy runs out of medication needed for a patient, so a nearby pharmacy loans them a bottle or a quantity of the drug. When the receiving pharmacy restocks, they pay it back. No paperwork. No tracking. Just professional courtesy.
But under today’s Drug Supply Chain Security Act (DSCSA), this long-standing practice is no longer a simple verbal agreement. In fact, Loan & Borrow often triggers regulatory obligations that many pharmacies don’t realize — and may put them at significant risk of noncompliance.
Here’s what pharmacies need to know.
What Is Loan & Borrow?
Loan & Borrow is the informal transfer of medication between pharmacies, typically to address unexpected stock-outs. Pharmacy A “loans” a medication to Pharmacy B, and Pharmacy B “returns” the same drug or quantity later.
This practice was harmless in a pre-DSCSA world.
Today, however, any movement of serialized product that changes ownership matters, and so does the electronic data that must accompany it.
Loan & Borrow = A Wholesale Transaction Under DSCSA
Yes. DSCSA defines a transaction as a transfer of product between persons in which a change of ownership occurs (1), so when a pharmacy loans a drug and later receives it back, the loan and the return are each a separate transaction with their own documentation. (1)
Many pharmacies are surprised to learn that Loan & Borrow is not exempt from DSCSA requirements. Even if the intention is to return the product later, DSCSA views each movement as a standalone transaction.
Here’s why:
1. Loaning the drug is one transaction.
Ownership transfers from Pharmacy A to Pharmacy B.
2. Returning the borrowed drug is a second transaction.
Ownership transfers back from Pharmacy B to Pharmacy A.
Under DSCSA, both transfers require:
- Transaction Information (TI)
- Transaction Statement (TS)
- Documentation stored for at least 6 years
That means Loan & Borrow isn’t an informal favor: it is regulated wholesale distribution.
Why Loan & Borrow Has Become a Compliance Risk
Loan & Borrow creates several challenges under DSCSA:
- No EPCIS outbound capability: Most pharmacies do not have systems to generate EPCIS transaction data, a requirement for any outbound DSCSA transaction after Nov. 27, 2023.
- Partial or open bottles cannot be transferred: DSCSA requires serialized tracing at the unit level, making mixed or open stock ineligible for compliant transfer.
- Pharmacies may unintentionally operate as unlicensed wholesalers: Pharmacies have operated under a 5% rule for many years. This rule came from DEA standards and stated that if more than 5% of prescription drug volume is transferred annually, a pharmacy may be classified as a wholesale distributor, triggering distributor licensing requirements. Under DSCSA there is no such carve out for limited distribution.
- Audit and enforcement exposure: State boards of pharmacy and FDA auditors may request documentation that most Loan & Borrow transactions cannot produce.
Put simply: Loan & Borrow without DSCSA-compliant data exchange is no longer a safe practice.
What About “Specific Patient Need”? Is That Exempt?
Yes, but this exemption is very narrow. (1)
A pharmacy may transfer product to another pharmacy, but only for the purpose of filling an existing prescription for a specific, identified patient, and only the exact amount needed to fill that prescription (1).
This exemption does not apply to traditional Loan & Borrow exchanges and does not allow transferring stock for replenishment or future use.
For almost all real-world Loan & Borrow situations, DSCSA rules apply.
Loan & Borrow vs. specific patient need transfer under DSCSA
|
Loan & Borrow (stock replenishment) |
Specific patient need transfer |
| Why the product moves |
To cover a stock-out or replenish inventory |
To fill an existing prescription for an identified patient |
| Quantity |
Any amount, often a full bottle or more |
Only the amount needed for that prescription |
| DSCSA treatment |
Each loan and each return is a separate transaction |
Excluded from the selling pharmacy's tracing documentation requirement (1) |
| TI and TS from the seller |
Required |
Not required |
The New Reality: Pharmacies Need Outbound EPCIS Capability
Under enhanced DSCSA requirements, every outbound transaction requires EPCIS data. If a pharmacy engages in:
- Clinic or sister-pharmacy replenishments
- Emergency medication exchanges
…that pharmacy must be able to generate outbound EPCIS files with fully serialized transaction data.
Without outbound EPCIS capability, Loan & Borrow is not compliant, even if it's only occasional or “just helping another pharmacy out.”
How LSPedia Helps Pharmacies Stay Compliant
LSPedia provides pharmacies with:
- Serialized data management that matches FDA and partner requirements
- Transaction documentation tools that store TI/TS data automatically
- Compliance workflows that prevent noncompliant transfers
- Integration with wholesalers, manufacturers, and care networks
Whether you perform transfers once a year or every week, LSPedia ensures every transaction is DSCSA-compliant, auditable, and secure.
Loan & Borrow isn’t going away but it must evolve to meet today’s regulatory environment.
Frequently asked questions
Is pharmacy Loan & Borrow allowed under DSCSA?
Yes, but only as a documented transaction. DSCSA defines a transaction as a transfer of product between persons in which a change of ownership occurs, so the loan and the return each count. Each one needs Transaction Information (TI) and a Transaction Statement (TS), both pharmacies must be authorized trading partners, and the records must be kept for at least 6 years.
Does returning a borrowed drug count as a second transaction?
Yes. When the borrowing pharmacy pays the loan back with product, ownership changes again, from the borrowing pharmacy back to the lending pharmacy. That return is a second, separate DSCSA transaction, so it needs its own Transaction Information and Transaction Statement, even when it is the same drug, strength and quantity that was originally loaned.
What counts as a “specific patient need” under DSCSA?
Under section 581(19) of the FD&C Act, a specific patient need is the transfer of a product from one pharmacy to another to fill a prescription for an identified patient. It does not include transfers to increase or replenish stock in anticipation of a potential need. Only the quantity needed for that prescription qualifies, so most Loan & Borrow exchanges do not.
Are small pharmacies exempt from DSCSA for Loan & Borrow?
Not from the transaction itself. FDA has exempted small dispensers, meaning pharmacies whose owning company has 25 or fewer full-time pharmacists and pharmacy technicians, from certain enhanced electronic, package-level tracing requirements until November 27, 2027 (2). Each loan and return is still a DSCSA transaction, and obligations such as trading only with authorized trading partners remain in effect.
How does OneScan Pharmacy Pro help with Loan & Borrow?
OneScan Pharmacy Pro generates outbound EPCIS data for pharmacy-to-pharmacy transfers, stores Transaction Information and Transaction Statements automatically, and applies compliance workflows that stop noncompliant transfers before they ship. That gives pharmacies an auditable record of every loan and every return when a state board of pharmacy, FDA or a trading partner asks for documentation.
Ensure Your Pharmacy Is DSCSA-Compliant
If your pharmacy engages in any Loan & Borrow or inter-pharmacy transfers, now is the time to ensure you have the systems and processes needed to comply with DSCSA.
Talk to LSPedia’s team today to confirm your pharmacy is compliant and equipped with outbound EPCIS capabilities.
👉 Contact LSPedia Sales: sales@lspedia.com
👉 Request a demo: Contact the LSPedia team
Your compliance and your patients’ safety depend on it!
Sources